A Study to Demonstrate the Efficacy and Safety of Motilitone®

• Status: Completed
• Trial end date: 2014-03-01
• Target enrollment: 0
• Participant gender: All

Summary

This is a phase IV , comparative study to evaluate the efficacy and safety of Motiltone® in treatment of the patients with functional dyspepsia. The study is conducted with following methods: multi-centers, double blind, randomization, parallel. The subjects will receive Motilitone® or/and Pantoline®.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Dong-A ST Co., Ltd.

Criteria

Inclusion Criteria:

• Roman III criteria

• One or more conditions are applied: epigastralgia, burning feelings in the solar plexus early satiety, uncomfortable fullness

• No organic lesion

Exclusion Criteria:

• has been administered or was administered within a month

• had a surgery that might affect gastrointestinal motility

• Tegaserod